Exact Mass: 387.170975
Exact Mass Matches: 387.170975
Found 500 metabolites which its exact mass value is equals to given mass value 387.170975
,
within given mass tolerance error 0.05 dalton. Try search metabolite list with more accurate mass tolerance error
0.01 dalton.
Terazosin
Terazosin is a selective alpha1-antagonist used for treatment of symptoms of benign prostatic hyperplasia (BPH). It also acts to lower blood pressure, so it is a drug of choice for men with hypertension and prostate enlargement. It works by blocking the action of adrenaline on smooth muscle of the bladder and the blood vessel walls. G - Genito urinary system and sex hormones > G04 - Urologicals > G04C - Drugs used in benign prostatic hypertrophy > G04CA - Alpha-adrenoreceptor antagonists C78272 - Agent Affecting Nervous System > C29747 - Adrenergic Agent > C72900 - Adrenergic Antagonist D018377 - Neurotransmitter Agents > D018663 - Adrenergic Agents > D018674 - Adrenergic Antagonists D000089162 - Genitourinary Agents > D064804 - Urological Agents
nemonapride
C21H26ClN3O2 (387.17134460000005)
D002492 - Central Nervous System Depressants > D014149 - Tranquilizing Agents > D014150 - Antipsychotic Agents D002491 - Central Nervous System Agents > D011619 - Psychotropic Drugs > D014149 - Tranquilizing Agents D018377 - Neurotransmitter Agents > D015259 - Dopamine Agents > D018492 - Dopamine Antagonists D002491 - Central Nervous System Agents > D002492 - Central Nervous System Depressants C78272 - Agent Affecting Nervous System > C66883 - Dopamine Antagonist C78272 - Agent Affecting Nervous System > C29710 - Antipsychotic Agent Same as: D01468
flurazepam
D002491 - Central Nervous System Agents > D002492 - Central Nervous System Depressants > D006993 - Hypnotics and Sedatives N - Nervous system > N05 - Psycholeptics > N05C - Hypnotics and sedatives > N05CD - Benzodiazepine derivatives D002492 - Central Nervous System Depressants > D014149 - Tranquilizing Agents > D014151 - Anti-Anxiety Agents D002491 - Central Nervous System Agents > D011619 - Psychotropic Drugs > D014149 - Tranquilizing Agents C78272 - Agent Affecting Nervous System > C29756 - Sedative and Hypnotic > C1012 - Benzodiazepine D018377 - Neurotransmitter Agents > D018682 - GABA Agents > D018757 - GABA Modulators C78272 - Agent Affecting Nervous System > C28197 - Antianxiety Agent CONFIDENCE standard compound; INTERNAL_ID 1631
A939572
A939572 is a potent, and orally bioavailable stearoyl-CoA desaturase1 (SCD1) inhibitor with IC50 values of <4 nM and 37 nM for mSCD1 and hSCD1, respectively.
Flurazepam
Flurazepam is only found in individuals that have used or taken this drug. It is a benzodiazepine derivative used mainly as a hypnotic. [PubChem]Flurazepam binds to an allosteric site on GABA-A receptors. Binding potentiates the action of GABA on GABA-A receptors by opening the chloride channel within the receptor, causing chloride influx and hyperpolarization. D002491 - Central Nervous System Agents > D002492 - Central Nervous System Depressants > D006993 - Hypnotics and Sedatives N - Nervous system > N05 - Psycholeptics > N05C - Hypnotics and sedatives > N05CD - Benzodiazepine derivatives D002492 - Central Nervous System Depressants > D014149 - Tranquilizing Agents > D014151 - Anti-Anxiety Agents D002491 - Central Nervous System Agents > D011619 - Psychotropic Drugs > D014149 - Tranquilizing Agents C78272 - Agent Affecting Nervous System > C29756 - Sedative and Hypnotic > C1012 - Benzodiazepine D018377 - Neurotransmitter Agents > D018682 - GABA Agents > D018757 - GABA Modulators C78272 - Agent Affecting Nervous System > C28197 - Antianxiety Agent
Dihydroxycitracridone I
C20H21NO7 (387.13179560000003)
Dihydroxycitracridone I is found in citrus. Dihydroxycitracridone I is isolated from roots of grapefruit plant
triazolopyridinone epoxide
triazolopyridinone epoxide is a metabolite of trazodone. Trazodone (also sold under the brand names Desyrel, Oleptro, Beneficat, Deprax, Desirel, Molipaxin, Thombran, Trazorel, Trialodine, Trittico, and Mesyrel) is an antidepressant of the serotonin antagonist and reuptake inhibitor (SARI) class. It is a phenylpiperazine compound. Trazodone also has anxiolytic and hypnotic effects. Trazodone has considerably fewer prominent anticholinergic and sexual side effects than most of the tricyclic antidepressants (TCAs). (Wikipedia)
4'-hydroxytrazodone
4-hydroxytrazodone is a metabolite of trazodone. Trazodone (also sold under the brand names Desyrel, Oleptro, Beneficat, Deprax, Desirel, Molipaxin, Thombran, Trazorel, Trialodine, Trittico, and Mesyrel) is an antidepressant of the serotonin antagonist and reuptake inhibitor (SARI) class. It is a phenylpiperazine compound. Trazodone also has anxiolytic and hypnotic effects. Trazodone has considerably fewer prominent anticholinergic and sexual side effects than most of the tricyclic antidepressants (TCAs). (Wikipedia)
4-(2-Chlorophenoxy)-N-[3-(methylcarbamoyl)phenyl]piperidine-1-carboxamide
A939572 is a potent, and orally bioavailable stearoyl-CoA desaturase1 (SCD1) inhibitor with IC50 values of <4 nM and 37 nM for mSCD1 and hSCD1, respectively.
1-[(6-Chloro-2-methoxyacridin-9-yl)amino]-3-(diethylamino)propan-2-ol
C21H26ClN3O2 (387.17134460000005)
4-Methyl-N-[4-[(4-nitrophenyl)azaniumyl]phenyl]-4-oxidopiperazin-4-ium-1-carboximidothioate
C18H21N5O3S (387.1365036000001)
DV 7751a
C20H22FN3O4 (387.15942640000003)
Falnidamol
C274 - Antineoplastic Agent > C163758 - Targeted Therapy Agent > C163952 - EGFR-targeting Agent C471 - Enzyme Inhibitor > C1404 - Protein Kinase Inhibitor > C1967 - Tyrosine Kinase Inhibitor
(2S,3S)-Nemonapride
C21H26ClN3O2 (387.17134460000005)
D002492 - Central Nervous System Depressants > D014149 - Tranquilizing Agents > D014150 - Antipsychotic Agents D002491 - Central Nervous System Agents > D011619 - Psychotropic Drugs > D014149 - Tranquilizing Agents D018377 - Neurotransmitter Agents > D015259 - Dopamine Agents > D018492 - Dopamine Antagonists D002491 - Central Nervous System Agents > D002492 - Central Nervous System Depressants
Pcera-1
C18H30NO6P (387.18106500000005)
Tegoprazan
trimebutine
C22H29NO5 (387.20456240000004)
A - Alimentary tract and metabolism > A03 - Drugs for functional gastrointestinal disorders > A03A - Drugs for functional gastrointestinal disorders > A03AA - Synthetic anticholinergics, esters with tertiary amino group D018373 - Peripheral Nervous System Agents > D001337 - Autonomic Agents > D010276 - Parasympatholytics C78272 - Agent Affecting Nervous System > C67413 - Opioid Receptor Agonist D005765 - Gastrointestinal Agents Trimebutine is a drug with antimuscarinic and weak mu opioid agonist effects. Target: Opioid Receptor Trimebutine is an agonist of peripheral mu, kappa and delta opiate receptors, used as spasmolytic agent for treatment of both acute and chronic abdominal pain [1]. The major product from drug metabolism of trimebutine in human beings is nor-trimebutine, which comes from removal of one of the methyl groups attached to nitrogen. Trimebutine exerts its effects in part due to causing a premature activation of phase III of the migrating motor complex in the digestive tract [2, 3].
(4-Ethylnaphthalen-1-yl)[1-(5-fluoropentyl)-1H-indol-3-yl]methanone
Benzyladenine 3-O-beta-D-glucoside
C18H21N5O5 (387.15426160000004)
Benzyladenine 3-o-beta-d-glucoside is a member of the class of compounds known as glycosylamines. Glycosylamines are compounds consisting of an amine with a beta-N-glycosidic bond to a carbohydrate, thus forming a cyclic hemiaminal ether bond (alpha-amino ether). Benzyladenine 3-o-beta-d-glucoside is slightly soluble (in water) and a very weakly acidic compound (based on its pKa). Benzyladenine 3-o-beta-d-glucoside can be found in soy bean, which makes benzyladenine 3-o-beta-d-glucoside a potential biomarker for the consumption of this food product.
Benzyladenine 7-O-beta-D-glucoside
C18H21N5O5 (387.15426160000004)
Benzyladenine 7-o-beta-d-glucoside is slightly soluble (in water) and a very weakly acidic compound (based on its pKa). Benzyladenine 7-o-beta-d-glucoside can be found in soy bean, which makes benzyladenine 7-o-beta-d-glucoside a potential biomarker for the consumption of this food product.
O-Methyltetradehydrotriphyophylline
C25H25NO3 (387.18343400000003)
6-(2Methoxybenzylamino)purine-9-beta-D-ribofuranoside
C18H21N5O5 (387.15426160000004)
2-(1-(cyclohexylmethyl)-1H-indazole-3-carboxamido)-3-methylsuccinicacid
trimebutine
C22H29NO5 (387.20456240000004)
A - Alimentary tract and metabolism > A03 - Drugs for functional gastrointestinal disorders > A03A - Drugs for functional gastrointestinal disorders > A03AA - Synthetic anticholinergics, esters with tertiary amino group D018373 - Peripheral Nervous System Agents > D001337 - Autonomic Agents > D010276 - Parasympatholytics C78272 - Agent Affecting Nervous System > C67413 - Opioid Receptor Agonist D005765 - Gastrointestinal Agents Trimebutine is a drug with antimuscarinic and weak mu opioid agonist effects. Target: Opioid Receptor Trimebutine is an agonist of peripheral mu, kappa and delta opiate receptors, used as spasmolytic agent for treatment of both acute and chronic abdominal pain [1]. The major product from drug metabolism of trimebutine in human beings is nor-trimebutine, which comes from removal of one of the methyl groups attached to nitrogen. Trimebutine exerts its effects in part due to causing a premature activation of phase III of the migrating motor complex in the digestive tract [2, 3].
18-chloro-12,15-dihydroxy-14xi-methyl-(12xiH,13xiH,15xiH)-15,20-dihydro-21-nor-senecionane-11,16-dione|Chlordesoxy-sceleratin
Cystodytin F
An alkaloid that is an enamide obtained by the formal condensation of 3-methylbut-2-enoic acid with 6-(2-amino-1-methoxyethyl)-4H-pyrido[2,3,4-kl]acridin-4-one. It is isolated from the Okinawan marine tunicate Cystodytes dellechiajei and exhibits cytotoxicity against human epidermoid carcinoma KB cells.
Jaconine
A pyrrolizine alkaloid that is jacoline in which the secondary hydroxy group has been replaced by a chlorine.
(+)-3alpha,6beta-diacetylbulbispermine
C20H21NO7 (387.13179560000003)
(7alpha,8beta,10beta)-8,10-epoxy-7,8-dimethoxy-2,3-[methylenebis(oxy)]-17-methyl-6,16-dioxohasubanan|periglaucine C
C20H21NO7 (387.13179560000003)
Cystodytin G
An alkaloid that is an enamide obtained by the formal condensation of tiglic acid with 6-(2-amino-1-methoxyethyl)-4H-pyrido[2,3,4-kl]acridin-4-one. It is isolated from the Okinawan marine tunicate Cystodytes dellechiajei and exhibits cytotoxicity against human epidermoid carcinoma KB cells
CAY10583
C25H25NO3 (387.18343400000003)
2-[6-(benzylamino)purin-7-yl]-6-(hydroxymethyl)oxane-3,4,5-triol
C18H21N5O5 (387.15426160000004)
N6-benzyladenine-9-glucoside (BA9G)
C18H21N5O5 (387.15426160000004)
Guanfu base I
C22H29NO5 (387.20456240000004)
2-(2-Methoxy-phenyl)-5-oxo-tetrahydro-furan-3-carboyl-lupinine
C22H29NO5 (387.20456240000004)
terazosin
G - Genito urinary system and sex hormones > G04 - Urologicals > G04C - Drugs used in benign prostatic hypertrophy > G04CA - Alpha-adrenoreceptor antagonists C78272 - Agent Affecting Nervous System > C29747 - Adrenergic Agent > C72900 - Adrenergic Antagonist D018377 - Neurotransmitter Agents > D018663 - Adrenergic Agents > D018674 - Adrenergic Antagonists D000089162 - Genitourinary Agents > D064804 - Urological Agents
Guanfu base Y
C22H29NO5 (387.20456240000004)
Origin: Plant; Formula(Parent): C22H29NO5; Bottle Name:Guan-fu base Y; PRIME Parent Name:Guan-fu base Y; PRIME in-house No.:V0331; SubCategory_DNP: Terpenoid alkaloids, Diterpene alkaloid, Aconitum alkaloid
Ala Ala Ile Asn
Ala Ala Leu Asn
Ala Ala Asn Ile
Ala Ala Asn Leu
Ala Ala Gln Val
Ala Ala Val Gln
Ala Gly Ile Gln
Ala Gly Leu Gln
Ala Gly Gln Ile
Ala Gly Gln Leu
Ala Ile Ala Asn
Ala Ile Gly Gln
Ala Ile Asn Ala
Ala Ile Gln Gly
Ala Leu Ala Asn
Ala Leu Gly Gln
Ala Leu Asn Ala
Ala Leu Gln Gly
Ala Asn Ala Ile
Ala Asn Ala Leu
Ala Asn Ile Ala
Ala Asn Leu Ala
Ala Asn Pro Ser
Ala Asn Ser Pro
Ala Pro Asn Ser
Ala Pro Ser Asn
Ala Gln Ala Val
Ala Gln Gly Ile
Ala Gln Gly Leu
Ala Gln Ile Gly
Ala Gln Leu Gly
Ala Gln Val Ala
Ala Ser Asn Pro
Ala Ser Pro Asn
Ala Val Ala Gln
Ala Val Gln Ala
Gly Ala Ile Gln
Gly Ala Leu Gln
Gly Ala Gln Ile
Gly Ala Gln Leu
Gly Ile Ala Gln
Gly Ile Gln Ala
Gly Lys Pro Ser
Gly Lys Ser Pro
Gly Leu Ala Gln
Gly Leu Gln Ala
Gly Asn Pro Thr
Gly Asn Thr Pro
Gly Asn Val Val
Gly Pro Lys Ser
Gly Pro Asn Thr
Gly Pro Gln Ser
Gly Pro Ser Lys
Gly Pro Ser Gln
Gly Pro Thr Asn
Gly Gln Ala Ile
Gly Gln Ala Leu
Gly Gln Ile Ala
Gly Gln Leu Ala
Gly Gln Pro Ser
Gly Gln Ser Pro
Gly Ser Lys Pro
Gly Ser Pro Lys
Gly Ser Pro Gln
Gly Ser Gln Pro
Gly Thr Asn Pro
Gly Thr Pro Asn
Gly Val Asn Val
Gly Val Val Asn
Ile Ala Ala Asn
Ile Ala Gly Gln
Ile Ala Asn Ala
Ile Ala Gln Gly
Ile Gly Ala Gln
Ile Gly Gln Ala
Ile Asn Ala Ala
Ile Gln Ala Gly
Ile Gln Gly Ala
Lys Gly Pro Ser
Lys Gly Ser Pro
Lys Pro Gly Ser
Lys Pro Ser Gly
Lys Ser Gly Pro
Lys Ser Pro Gly
Leu Ala Ala Asn
Leu Ala Gly Gln
Leu Ala Asn Ala
Leu Ala Gln Gly
Leu Gly Ala Gln
Leu Gly Gln Ala
Leu Asn Ala Ala
Leu Gln Ala Gly
Leu Gln Gly Ala
Asn Ala Ala Ile
Asn Ala Ala Leu
Asn Ala Ile Ala
Asn Ala Leu Ala
Asn Ala Pro Ser
Asn Ala Ser Pro
Asn Gly Pro Thr
Asn Gly Thr Pro
Asn Gly Val Val
Asn Ile Ala Ala
Asn Leu Ala Ala
Asn Pro Ala Ser
Asn Pro Gly Thr
Asn Pro Ser Ala
Asn Pro Thr Gly
Asn Ser Ala Pro
Asn Ser Pro Ala
Asn Thr Gly Pro
Asn Thr Pro Gly
Asn Val Gly Val
Asn Val Val Gly
Pro Ala Asn Ser
Pro Ala Ser Asn
Pro Gly Lys Ser
Pro Gly Asn Thr
Pro Gly Gln Ser
Pro Gly Ser Lys
Pro Gly Ser Gln
Pro Gly Thr Asn
Pro Lys Gly Ser
Pro Lys Ser Gly
Pro Asn Ala Ser
Pro Asn Gly Thr
Pro Asn Ser Ala
Pro Asn Thr Gly
Pro Gln Gly Ser
Pro Gln Ser Gly
Pro Ser Ala Asn
Pro Ser Gly Lys
Pro Ser Gly Gln
Pro Ser Lys Gly
Pro Ser Asn Ala
Pro Ser Gln Gly
Pro Thr Gly Asn
Pro Thr Asn Gly
Gln Ala Ala Val
Gln Ala Gly Ile
Gln Ala Gly Leu
Gln Ala Ile Gly
Gln Ala Leu Gly
Gln Ala Val Ala
Gln Gly Pro Ser
Gln Gly Ser Pro
Gln Pro Gly Ser
Gln Pro Ser Gly
Gln Ser Gly Pro
Gln Ser Pro Gly
Ser Ala Asn Pro
Ser Ala Pro Asn
Ser Gly Pro Gln
Ser Gly Gln Pro
Ser Asn Ala Pro
Ser Asn Pro Ala
Ser Pro Ala Asn
Ser Pro Gly Gln
Ser Pro Asn Ala
Ser Pro Gln Gly
Ser Gln Gly Pro
Ser Gln Pro Gly
Thr Gly Asn Pro
Thr Gly Pro Asn
Thr Asn Gly Pro
Thr Asn Pro Gly
Thr Pro Gly Asn
Thr Pro Asn Gly
2-Hydroxyiminodibenzyl glucuronide
C20H21NO7 (387.13179560000003)
Dihydroxycitracridone I
C20H21NO7 (387.13179560000003)
14-carboxy-15,16,17,18,19,20-hexanor-leukotriene E3
An icosanoid that is leukotriene E3 in which the terminal octyl group is replaced by a carboxymethyl group.
(2R,3S)-2-AMINO-3-(BENZO[D][1,3]DIOXOL-5-YL)-3-HYDROXYPROPANOIC ACID
C24H21NO4 (387.14705060000006)
3-(FMOC-4-AMINOPHENYL)-PROPIONIC ACID
C24H21NO4 (387.14705060000006)
2-FLUORO-3-ETHOXY-6-BROMOPHENYLBORONIC ACID
C24H21NO4 (387.14705060000006)
Urea, N-[(2-chloro-6-ethoxy-3-quinolinyl)methyl]-N-(2-furanylmethyl)-N,N-dimethyl- (9CI)
((((2-(6-Amino-9H-purin-9-yl)ethoxy)methyl)(hydroxy)phosphoryl)oxy)methyl pivalate
C14H22N5O6P (387.13076420000004)
hexyl 6-aminohexanoate,4-methylbenzenesulfonic acid
C19H33NO5S (387.2079328000001)
N-Benzoxycarbonyl-5-(methylsulfonyloxy)-L-norvaline, iso-propyl ester
N-(hydroxymethyl)-2-methylprop-2-enamide,2-methylidenebutanoic acid,methyl 2-methylprop-2-enoate,prop-2-enoic acid
(2R,3S)-Benzyl6-oxo-2,3-diphenylmorpholine-4-carboxylate
C24H21NO4 (387.14705060000006)
Fmoc-(4-aminomethylphenyl)acetic acid
C24H21NO4 (387.14705060000006)
Fmoc-3-amino-3-phenylpropionic acid
C24H21NO4 (387.14705060000006)
Fmoc-(R)-3-Amino-3-phenylpropionic acid
C24H21NO4 (387.14705060000006)
N,N,2,6-TETRAMETHYLDINAPHTHO[2,1-D:1,2-F][1,3,2]DIOXAPHOSPHEPIN-4-AMINE
[5-(4-methylpiperazine-1-carbonyl)-1-[(2-methylpropan-2-yl)oxycarbonyl]indol-2-yl]boronic acid
C19H26BN3O5 (387.19654160000005)
endo-8-Methyl-8-azabicyclo[3.2.1]octan-3-yl 2-hydroxy-2,2-diphenylacetate hydrochloride
C22H26ClNO3 (387.16011160000005)
FMOC-3-AMINOMETHYL-PHENYLACETIC ACID
C24H21NO4 (387.14705060000006)
N-[(1,1-Dimethylethoxy)carbonyl]-S-(diphenylmethyl)-L-cysteine
C21H25NO4S (387.15042100000005)
N-(tert-butoxycarbonyl)-3,4-dihydroxy-L-Pheny lalanine benzyl ester
1-[(TERT-BUTYL)OXYCARBONYL]-3-[4-(TRIFLUOROMETHYL)BENZYL]PIPERIDINE-3-CARBOXYLIC ACID
C19H24F3NO4 (387.16573400000004)
N-[(2S,3R)-1-benzyl-2-methylpyrrolidin-3-yl]-5-chloro-2-methoxy-4-(methylamino)benzamide
C21H26ClN3O2 (387.17134460000005)
(R)-3-((((9H-Fluoren-9-yl)methoxy)carbonyl)amino)-2-phenylpropanoic acid
C24H21NO4 (387.14705060000006)
Ethyl 2-(acetylamino)-3-[3,5-diamino-4-(4-methoxyphenoxy)phenyl]propanoate
4-(1-(1-ethoxyethyl)-1h-pyrazol-4-yl)-7-((2-(trimethylsilyl)ethoxy)methyl)-7h-pyrrolo(2,3-d)pyrimidine
(20R)-20-chloro-12,15-dihydroxy-(15αH)-15,20-dihydro-senecionane-11,16-dione
Allyl 2-Acetamido-3,4,6-tri-O-acetyl-2-deoxy--D-glucopyranoside
Fmoc-(S)-3-Amino-3-phenylpropionic acid
C24H21NO4 (387.14705060000006)
Benzyl 2-chloro-4-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)phenylcarbamate
C20H23BClNO4 (387.14085780000005)
(4S)-tert-Butyl-2-[2-(diphenylphosphino)phenyl]-4,5-dihydrooxazole
C25H26NOP (387.17519160000006)
(2S,3R)-Benzyl 6-oxo-2,3-diphenylmorpholine-4-carboxylate
C24H21NO4 (387.14705060000006)
ETHYL 4-(2-(4-CYANOPHENYLAMINO)PYRIMIDIN-4-YLAMINO)-3,5-DIMETHYLBENZOATE
6-Benzylaminopurine 9-(beta-D-glucoside)
C18H21N5O5 (387.15426160000004)
Dipivefrin HCl
C19H30ClNO5 (387.18124000000006)
D018377 - Neurotransmitter Agents > D018663 - Adrenergic Agents > D000322 - Adrenergic Agonists C78283 - Agent Affecting Organs of Special Senses > C29705 - Anti-glaucoma Agent
(S)-N,N-Diethyldinaphtho[2,1-d:1,2-f][1,3,2]dioxaphosphepin-4-amine
9-(2-Carboxyphenyl)-3,6-bis(dimethylamino)xanthylium
1-Piperazinecarbothioamide, 4-methyl-N-(4-((4-nitrophenyl)amino)phenyl)-, 4-oxide
C18H21N5O3S (387.1365036000001)
7-[oxo-(4-phenyl-3,6-dihydro-2H-pyridin-1-yl)methyl]-3-prop-2-enyl-1H-quinazoline-2,4-dione
7-[(Z)-3-Chlorobut-2-enyl]-1,3-dimethyl-8-(2-phenylethylamino)purine-2,6-dione
Cyclopentanecarboxylic acid [1-(benzothiazole-2-carbonyl)-4-guanidino-butyl]-amide
4-[3-(Dibenzylamino)phenyl]-2,4-dioxobutanoic acid
C24H21NO4 (387.14705060000006)
4-{[5-(Cyclohexylamino)[1,2,4]triazolo[1,5-A]pyrimidin-7-YL]amino}benzenesulfonamide
C17H21N7O2S (387.14773660000003)
4-[5-(4,5-dihydro-1H-imidazol-2-yl)-2-methoxyphenyl]-1-[3-(4,5-dihydro-1H-imidazol-2-yl)phenyl]triazole
3,4-dihydro-1H-isoquinolin-2-yl-[1-(6-pyrrol-1-ylpyrimidin-4-yl)piperidin-4-yl]methanone
N-(3-imidazol-1-ylpropyl)-8-(4-methoxyphenyl)-1,6-naphthyridine-2-carboxamide
4-[4-(4,5-dihydro-1H-imidazol-2-yl)-2-methoxyphenyl]-1-[3-(4,5-dihydro-1H-imidazol-2-yl)phenyl]triazole
1-[4-(4,5-dihydro-1H-imidazol-2-yl)-2-methoxyphenyl]-4-[3-(4,5-dihydro-1H-imidazol-2-yl)phenyl]triazole
(9,10,19-Trihydroxy-5-methyl-12-methylidene-7-azaheptacyclo[9.6.2.01,8.05,17.07,16.09,14.014,18]nonadecan-3-yl) acetate
C22H29NO5 (387.20456240000004)
2-{4-[(N-phenylpentanamido)methyl]phenyl}benzoic acid
C25H25NO3 (387.18343400000003)
N-benzyl-9-(alpha-D-glucosyl)adenine
C18H21N5O5 (387.15426160000004)
(3Z)-3-[(2E,4E,6R)-1-hydroxy-4-methyl-6-[(3R,4S)-1,4,8-trimethyl-2,9-dioxabicyclo[3.3.1]non-7-en-3-yl]hepta-2,4-dienylidene]pyrrolidine-2,4-dione
C22H29NO5 (387.20456240000004)
(2E,4E)-5-[(1R,7S,8S,9R)-7-acetyloxy-4,9-dimethyl-11-oxo-10-oxatricyclo[6.3.2.01,7]tridec-3-en-9-yl]-2-methylpenta-2,4-dienoate
2-Amino-7-[2-[2-(2-amino-6-oxo-1,9-dihydropurin-7-ium-7-yl)ethyl-methylamino]ethyl]-1,9-dihydropurin-7-ium-6-one
(Z)-5-[(1S,2R)-2-[2-[[(1S)-1-carboxy-2-phenylethyl]amino]-2-oxoethyl]-5-oxocyclopentyl]pent-3-enoic acid
Benzyladenine 7-O-beta-D-glucoside
C18H21N5O5 (387.15426160000004)
(2S,3S)-Nemonapride
C21H26ClN3O2 (387.17134460000005)
D002492 - Central Nervous System Depressants > D014149 - Tranquilizing Agents > D014150 - Antipsychotic Agents D002491 - Central Nervous System Agents > D011619 - Psychotropic Drugs > D014149 - Tranquilizing Agents D018377 - Neurotransmitter Agents > D015259 - Dopamine Agents > D018492 - Dopamine Antagonists D002491 - Central Nervous System Agents > D002492 - Central Nervous System Depressants
periglaucine C
C20H21NO7 (387.13179560000003)
A natural product found in Pericampylus glaucus.
N-(5-methyl-3-isoxazolyl)-2-(4-propan-2-yloxyphenyl)-4-quinolinecarboxamide
2-(2-hydroxyphenyl)-3-[(E)-1-(4-methoxyphenyl)ethylideneamino]-1,2-dihydroquinazolin-4-one
4-[[2-[4-(4-Chlorophenyl)-1-piperazinyl]-1-oxoethyl]amino]benzoic acid methyl ester
2-benzoyl-N-(6-methoxy-3-pyridinyl)-3,4-dihydro-1H-isoquinoline-3-carboxamide
9-[2-hydroxy-3-(2-methyl-1-benzimidazolyl)propyl]-6-methyl-3,4-dihydro-2H-carbazol-1-one
3-fluoro-N-[1-[2-[(2-fluorophenyl)methylamino]-2-oxoethyl]-4-piperidinyl]benzamide
C21H23F2N3O2 (387.17582419999997)
3-Furanyl-[4-(5-methyl-2-phenyl-7-pyrazolo[1,5-a]pyrimidinyl)-1-piperazinyl]methanone
1-Cyclohexyl-5-[1-(2,4-dimethoxyanilino)ethylidene]-1,3-diazinane-2,4,6-trione
4-methyl-N-[2-methyl-1,3-bis[(4-methyl-1,2,5-oxadiazol-3-yl)oxy]propan-2-yl]benzamide
C18H21N5O5 (387.15426160000004)
2-(1-Adamantyl)-4-chloro-5-[(4-fluorophenyl)methylamino]-3-pyridazinone
N2-(3-Chloro-4-methylphenyl)-N1-(4-methoxyphenyl)pyrrolidine-1,2-dicarboxamide
2-Amino-4-[4-(methylthio)phenyl]-5-oxo-1-phenyl-4,6,7,8-tetrahydroquinoline-3-carbonitrile
C23H21N3OS (387.14052560000005)
1-[2,5-Dimethyl-1-(phenylmethyl)-3-pyrrolyl]-2-[4-(1,3,4-oxadiazol-2-yl)phenoxy]ethanone
N-[3-chloro-4-(4-methyl-1-piperazinyl)phenyl]-2,3-dihydro-1,4-benzodioxin-6-carboxamide
6-Amino-5-[2-[4-(2-methoxyphenyl)-1-piperazinyl]-1-oxoethyl]-1,3-dimethylpyrimidine-2,4-dione
N-(5-cyclopropyl-1,3,4-thiadiazol-2-yl)-4-(4-methyl-1-piperidinyl)-3-nitrobenzamide
C18H21N5O3S (387.1365036000001)
2-(1,3-Benzoxazol-2-ylamino)-7,7-dimethyl-4-(2-pyridinyl)-1,4,6,8-tetrahydroquinazolin-5-one
6-ethyl-8-methyl-N-(3-pyridinylmethyl)-3-benzo[b][1,4]benzothiazepinecarboxamide
C23H21N3OS (387.14052560000005)
2-(4-Methylphenyl)-2-oxo-1-phenylethyl 3-(acetylamino)benzoate
C24H21NO4 (387.14705060000006)
5-fluoro-N-[(3R)-1-(1H-indol-5-ylmethyl)-3-pyrrolidinyl]-2-methylbenzenesulfonamide
N-[4-[[[6-(3,5-dimethyl-4-isoxazolyl)-4-quinazolinyl]amino]methyl]phenyl]acetamide
(4E,8E)-10-(4-hydroxy-6-methoxy-7-methyl-3-oxo-1,3-dihydro-2-benzofuran-5-yl)-4,8-dimethyldeca-4,8-dienoate
1-(4-(5-(Furan-2-yl)-2-phenylpyrazolo[1,5-a]pyrimidin-7-yl)piperazin-1-yl)ethanone
N-[2-[(2E)-2-[(3-hydroxyphenyl)methylidene]hydrazinyl]-2-oxoethyl]-2,2-diphenylacetamide
(2S,3R,4S)-3,4-dihydroxy-2-((6-(3-methylbut-2-en-1-yl)-1H-indole-3-carbonyl)oxy)-3,4-dihydro-2H-pyran-6-carboxylic acid
C20H21NO7 (387.13179560000003)
4-[(3aS,4S,9bS)-1-[cyclobutyl(oxo)methyl]-4-(hydroxymethyl)-2,3,3a,4,5,9b-hexahydropyrrolo[3,2-c]quinolin-8-yl]benzonitrile
(2S,3S,4S)-3-[4-(cyclohexen-1-yl)phenyl]-4-(hydroxymethyl)-1-(2-pyridin-4-ylacetyl)azetidine-2-carbonitrile
(2R,3R,4S)-3-[4-(1-cyclohexenyl)phenyl]-4-(hydroxymethyl)-1-(1-oxo-2-pyridin-4-ylethyl)-2-azetidinecarbonitrile
(2S,3R,4S)-3-[4-(1-cyclohexenyl)phenyl]-4-(hydroxymethyl)-1-(1-oxo-2-pyridin-4-ylethyl)-2-azetidinecarbonitrile
(2S,3R,4R)-3-[4-(cyclohexen-1-yl)phenyl]-4-(hydroxymethyl)-1-(2-pyridin-4-ylacetyl)azetidine-2-carbonitrile
(2R,3S)-8-(2-fluorophenyl)-5-[(2S)-1-hydroxypropan-2-yl]-3-methyl-2-(methylaminomethyl)-3,4-dihydro-2H-pyrido[2,3-b][1,5]oxazocin-6-one
(2S,3R)-8-(2-fluorophenyl)-5-[(2R)-1-hydroxypropan-2-yl]-3-methyl-2-(methylaminomethyl)-3,4-dihydro-2H-pyrido[2,3-b][1,5]oxazocin-6-one
(2S,3R)-8-(2-fluorophenyl)-5-[(2S)-1-hydroxypropan-2-yl]-3-methyl-2-(methylaminomethyl)-3,4-dihydro-2H-pyrido[2,3-b][1,5]oxazocin-6-one
(2R,3R,4R)-3-[4-(1-cyclohexenyl)phenyl]-4-(hydroxymethyl)-1-(1-oxo-2-pyridin-4-ylethyl)-2-azetidinecarbonitrile
1-[(1S,5R)-7-[4-(4-fluorophenyl)phenyl]-3,6-diazabicyclo[3.1.1]heptan-3-yl]-2-pyridin-4-ylethanone
N-[(E)-(5-fluoro-2-hydroxyphenyl)methylideneamino]-N-(2-hydroxyphenyl)heptanediamide
C20H22FN3O4 (387.15942640000003)
(2R,3S)-8-(2-fluorophenyl)-5-[(2R)-1-hydroxypropan-2-yl]-3-methyl-2-(methylaminomethyl)-3,4-dihydro-2H-pyrido[2,3-b][1,5]oxazocin-6-one
(2R,3S,4S)-3-[4-(1-cyclohexenyl)phenyl]-4-(hydroxymethyl)-1-(1-oxo-2-pyridin-4-ylethyl)-2-azetidinecarbonitrile
[(2S,3R)-3-phenyl-6-(2-pyridinylmethyl)-1-(5-pyrimidinylmethyl)-1,6-diazaspiro[3.3]heptan-2-yl]methanol
[(2R,3R)-3-phenyl-6-(2-pyridinylmethyl)-1-(5-pyrimidinylmethyl)-1,6-diazaspiro[3.3]heptan-2-yl]methanol
(2aR,7R,7aS,7bR)-7b-hydroxy-7-{[(1S,2S,4aR,8aR)-2,4a,8a-trimethyl-1,2,4a,5,6,7,8,8a-octahydronaphthalen-1-yl]carbonyl}hexahydrofuro[2,3,4-gh]pyrrolizine-2,6-dione
C22H29NO5 (387.20456240000004)
N(2)-[(2Z)-2-(2-amino-1,3-thiazol-4-yl)-2-(methoxyimino)acetyl]-N-butyl-3,3-dimethoxyalaninamide
C15H25N5O5S (387.15763200000004)
[(1R)-2,3,4,6,7,8,9,9a-octahydro-1H-quinolizin-1-yl]methyl 2-(2-methoxyphenyl)-5-oxooxolane-3-carboxylate
C22H29NO5 (387.20456240000004)
[(1S,5R,8R,9R,11R,14S,16S,17R,18S,19S)-9,10,19-trihydroxy-5-methyl-12-methylidene-7-azaheptacyclo[9.6.2.01,8.05,17.07,16.09,14.014,18]nonadecan-3-yl] acetate
C22H29NO5 (387.20456240000004)
[(1S,5R,8R,9R,11R,16S,17R,18S,19S)-9,10,19-trihydroxy-5-methyl-12-methylidene-7-azaheptacyclo[9.6.2.01,8.05,17.07,16.09,14.014,18]nonadecan-3-yl] acetate
C22H29NO5 (387.20456240000004)
Falnidamol
C274 - Antineoplastic Agent > C163758 - Targeted Therapy Agent > C163952 - EGFR-targeting Agent C471 - Enzyme Inhibitor > C1404 - Protein Kinase Inhibitor > C1967 - Tyrosine Kinase Inhibitor
N-(1-benzyl-2-methylpyrrolidin-3-yl)-5-chloro-2-methoxy-4-(methylamino)benzamide
C21H26ClN3O2 (387.17134460000005)
D002492 - Central Nervous System Depressants > D014149 - Tranquilizing Agents > D014150 - Antipsychotic Agents D002491 - Central Nervous System Agents > D011619 - Psychotropic Drugs > D014149 - Tranquilizing Agents D018377 - Neurotransmitter Agents > D015259 - Dopamine Agents > D018492 - Dopamine Antagonists D002491 - Central Nervous System Agents > D002492 - Central Nervous System Depressants
stemofoline
C22H29NO5 (387.20456240000004)
A natural product found in Stemona curtisii and Stemona aphylla.
UCS1025 A
C22H29NO5 (387.20456240000004)
An organic heterotricyclic compound that incorporates a lactam and a gamma-lactone as part of the cyclic system which in turn is attached to a (2,4a,8a-trimethyl-octahydronaphthalen-1-yl)carbonyl group at position 7. It is isolated from Acremonium sp. KY4917 and exhibits antibacterial activity.
N-acetyl-D-galactosamine-6-phosphocholine
A galactose phosphate consisting of N-acetyl-D-galactosamine having a choline phosphate group at the 6-position.
(R)-Terazosin
(R)-Terazosin is an active R-enantiomer of Terazosin. (R)-Terazosin is a potent α1-adrenoceptor antagonist with Ki values of 6.51 nM, 1.01 nM and 1.97 nM for α1a, α1b and α1d-adrenoceptor, respectively[1].
(S)-Terazosin
(S)-Terazosin is an active S-enantiomer of Terazosin. (S)-Terazosin is a potent and high-affinity α-adrenoceptor antagonist with Ki values of 3.91 nM, 0.79 nM and 1.16 nM for α1a, α1b and α1d-adrenoceptor, respectively. (S)-Terazosin also has high-affinity for α2a, α2B and α2c-adrenoceptor with Ki values of 729 nM, 3.5 nM and 46.4 nM, respectively[1].
MHY1485
C17H21N7O4 (387.16549460000005)
MHY1485 is a potent cell-permeable mTOR activator that targets the ATP domain of mTOR. MHY1485 inhibits autophagy by suppression of fusion between autophagosomes and lysosomes[1]. MHY1485 is a potent cell-permeable mTOR activator that targets the ATP domain of mTOR. MHY1485 inhibits autophagy by suppression of fusion between autophagosomes and lysosomes[1].
SSD114 (hydrochloride)
C18H21ClF3N3O (387.13251620000005)
SSD114 hydrochloride is a novel GABAB receptor positive allosteric modulator.
5-[(1s,3z,4s,5r,6s,8r,9s)-9-butyl-4-methyl-2,14-dioxa-10-azapentacyclo[6.5.1.0¹,⁵.0⁶,¹⁰.0⁹,¹³]tetradecan-3-ylidene]-4-methoxy-3-methylfuran-2-one
C22H29NO5 (387.20456240000004)
(1r,10s)-3,4,11,12-tetramethoxy-17-methyl-17-azatetracyclo[8.4.3.0¹,¹⁰.0²,⁷]heptadeca-2,4,6,11-tetraene-13,16-dione
5,17-dihydroxy-3,4,16-trimethoxy-11-methyl-11-azatetracyclo[8.7.1.0²,⁷.0¹⁴,¹⁸]octadeca-1(17),2(7),3,5,14(18),15-hexaen-11-ium-11-olate
5-[(1s,3e,4s,5r,6s,8s,9s,13r)-9-butyl-4-methyl-2,14-dioxa-10-azapentacyclo[6.5.1.0¹,⁵.0⁶,¹⁰.0⁹,¹³]tetradecan-3-ylidene]-4-methoxy-3-methylfuran-2-one
C22H29NO5 (387.20456240000004)
(4z)-5-hydroxy-4-[(2e,6r)-1-hydroxy-4-methyl-6-[(1r,3r,4s,5r)-1,4,8-trimethyl-2,9-dioxabicyclo[3.3.1]non-7-en-3-yl]hepta-2,4-dien-1-ylidene]-2h-pyrrol-3-one
C22H29NO5 (387.20456240000004)
4,5-dihydroxy-6-[5-(3-methylbut-2-en-1-yl)-1h-indole-3-carbonyloxy]-5,6-dihydro-4h-pyran-2-carboxylic acid
C20H21NO7 (387.13179560000003)
14,15-dimethoxy-20-methyl-5,7,21-trioxa-20-azahexacyclo[11.4.3.1¹¹,¹⁴.0¹,¹³.0²,¹⁰.0⁴,⁸]henicosa-2,4(8),9-triene-16,19-dione
C20H21NO7 (387.13179560000003)
4-(1-chloroethyl)-4,7-dihydroxy-6,7-dimethyl-2,9-dioxa-14-azatricyclo[9.5.1.0¹⁴,¹⁷]heptadec-11-ene-3,8-dione
(5s)-5-{[2-(hydroxymethyl)-3,4-dimethoxyphenyl]methyl}-6-methyl-2h,5h,7h,8h-[1,3]dioxolo[4,5-g]isoquinolin-4-ol
5-{[2-(hydroxymethyl)-3,4-dimethoxyphenyl]methyl}-6-methyl-2h,5h,7h,8h-[1,3]dioxolo[4,5-g]isoquinolin-4-ol
methyl 3,5-dimethoxy-2-{5-methoxy-4-oxo-6-[(1e)-prop-1-en-1-yl]-1h-pyridine-3-carbonyl}benzoate
C20H21NO7 (387.13179560000003)
16-oxohasubanonine
{"Ingredient_id": "HBIN001944","Ingredient_name": "16-oxohasubanonine","Alias": "NA","Ingredient_formula": "C21H25NO6","Ingredient_Smile": "Not Available","Ingredient_weight": "NA","OB_score": "NA","CAS_id": "NA","SymMap_id": "NA","TCMID_id": "16330","TCMSP_id": "NA","TCM_ID_id": "NA","PubChem_id": "NA","DrugBank_id": "NA"}
9-methoxy-10-methyl-4,17-dioxa-2,14,22-triazaheptacyclo[11.10.0.0²,⁶.0³,²¹.0⁷,¹².0¹⁴,¹⁸.0¹⁹,²³]tricosa-7,9,11-triene-8,11-diol
n-(2-methoxy-2-{12-oxo-8,14-diazatetracyclo[7.7.1.0²,⁷.0¹³,¹⁷]heptadeca-1(17),2(7),3,5,8,10,13,15-octaen-10-yl}ethyl)-3-methylbut-2-enimidic acid
(1s,5r)-3-[(3-hydroxy-2-phenylpropanoyl)oxy]-8-methyl-8-azabicyclo[3.2.1]octan-6-yl (2e)-2-methylbut-2-enoate
C22H29NO5 (387.20456240000004)
2,6,18-trihydroxy-5-methyl-12-methylidene-7-azaheptacyclo[9.6.2.0¹,⁸.0⁵,¹⁷.0⁷,¹⁶.0⁹,¹⁴.0¹⁴,¹⁸]nonadecan-3-yl acetate
C22H29NO5 (387.20456240000004)
5-[(1s,3s,4r,5s,6z,10r,13r)-13-butyl-5-methyl-7,14-dioxa-12-azatetracyclo[8.3.1.0³,¹².0⁴,⁸]tetradec-8-en-6-ylidene]-4-methoxy-3-methylfuran-2-one
C22H29NO5 (387.20456240000004)
[(1r,3r)-10-hydroxy-7-(methylamino)-1-(3-methylbutyl)-6,9-dioxo-1h,3h,4h-naphtho[2,3-c]pyran-3-yl]acetic acid
3-(2-{7,7-dimethyl-3h-chromeno[6,5-b]pyrrol-1-yl}ethyl)-2-hydroxyquinazolin-4-one
3,6,19-trihydroxy-5-methyl-12-methylidene-7-azaheptacyclo[9.6.2.0¹,⁸.0⁵,¹⁷.0⁷,¹⁶.0⁹,¹⁴.0¹⁴,¹⁸]nonadecan-10-yl acetate
C22H29NO5 (387.20456240000004)
3-({2-[(1-hydroxy-4-methylhexa-2,4-dien-1-ylidene)amino]-3-phenylbutanoyl}oxy)-2-methylbutanoic acid
C22H29NO5 (387.20456240000004)
5-{9-butyl-4-methyl-2,14-dioxa-10-azapentacyclo[6.5.1.0¹,⁵.0⁶,¹⁰.0⁹,¹³]tetradecan-3-ylidene}-4-methoxy-3-methylfuran-2-one
C22H29NO5 (387.20456240000004)
(1r,4r,5r,8r,9s,10s,11r,14r,16r,17s,18r,19r)-4,16,19-trihydroxy-5-methyl-12-methylidene-7-azaheptacyclo[9.6.2.0¹,⁸.0⁵,¹⁷.0⁷,¹⁶.0⁹,¹⁴.0¹⁴,¹⁸]nonadecan-10-yl acetate
C22H29NO5 (387.20456240000004)
7-(chloromethyl)-4,7-dihydroxy-4,5,6-trimethyl-2,9-dioxa-14-azatricyclo[9.5.1.0¹⁴,¹⁷]heptadec-11-ene-3,8-dione
(1r,3r,6r,13r,18r,19s,21s,23r)-9-methoxy-10-methyl-4,17-dioxa-2,14,22-triazaheptacyclo[11.10.0.0²,⁶.0³,²¹.0⁷,¹².0¹⁴,¹⁸.0¹⁹,²³]tricosa-7,9,11-triene-8,11-diol
(19s,21s)-9-methoxy-10-methyl-4,17-dioxa-2,14,22-triazaheptacyclo[11.10.0.0²,⁶.0³,²¹.0⁷,¹².0¹⁴,¹⁸.0¹⁹,²³]tricosa-7,9,11-triene-8,11-diol
(1s,4s,5r,6s,7s,17s)-7-(chloromethyl)-4,7-dihydroxy-4,5,6-trimethyl-2,9-dioxa-14-azatricyclo[9.5.1.0¹⁴,¹⁷]heptadec-11-ene-3,8-dione
methyl 3,5-dimethoxy-2-[5-methoxy-4-oxo-6-(prop-1-en-1-yl)-1h-pyridine-3-carbonyl]benzoate
C20H21NO7 (387.13179560000003)
(2e)-n-(2-methoxy-2-{12-oxo-8,14-diazatetracyclo[7.7.1.0²,⁷.0¹³,¹⁷]heptadeca-1(17),2(7),3,5,8,10,13,15-octaen-10-yl}ethyl)-2-methylbut-2-enimidic acid
(1s,4e,9r)-6-hydroxy-4-(3h-imidazol-4-ylmethylidene)-9-(2-methylbut-3-en-2-yl)-2,5,16-triazatetracyclo[7.7.0.0²,⁷.0¹⁰,¹⁵]hexadeca-5,7,10,12,14-pentaen-3-one
(1r,7s)-4-ethylidene-7-methyl-6-methylidene-3,8,15-trioxo-2,9-dioxa-14-azatricyclo[9.5.1.0¹⁴,¹⁷]heptadeca-11(17),12-dien-7-yl acetate
C20H21NO7 (387.13179560000003)
3,4,11,12-tetramethoxy-17-methyl-17-azatetracyclo[8.4.3.0¹,¹⁰.0²,⁷]heptadeca-2,4,6,11-tetraene-13,16-dione
4,16,19-trihydroxy-5-methyl-12-methylidene-7-azaheptacyclo[9.6.2.0¹,⁸.0⁵,¹⁷.0⁷,¹⁶.0⁹,¹⁴.0¹⁴,¹⁸]nonadecan-10-yl acetate
C22H29NO5 (387.20456240000004)
9,10,19-trihydroxy-5-methyl-12-methylidene-7-azaheptacyclo[9.6.2.0¹,⁸.0⁵,¹⁷.0⁷,¹⁶.0⁹,¹⁴.0¹⁴,¹⁸]nonadecan-3-yl acetate
C22H29NO5 (387.20456240000004)
5-[(1r,3z,4s,5r,6s,8s,9s,13r)-9-butyl-4-methyl-2,14-dioxa-10-azapentacyclo[6.5.1.0¹,⁵.0⁶,¹⁰.0⁹,¹³]tetradecan-3-ylidene]-4-methoxy-3-methylfuran-2-one
C22H29NO5 (387.20456240000004)
5-[(1s,3s,4r,5r,6z,10r,13r)-13-butyl-5-methyl-7,14-dioxa-12-azatetracyclo[8.3.1.0³,¹².0⁴,⁸]tetradec-8-en-6-ylidene]-4-methoxy-3-methylfuran-2-one
C22H29NO5 (387.20456240000004)
5-[(3e)-9-butyl-4-methyl-2,14-dioxa-10-azapentacyclo[6.5.1.0¹,⁵.0⁶,¹⁰.0⁹,¹³]tetradecan-3-ylidene]-4-methoxy-3-methylfuran-2-one
C22H29NO5 (387.20456240000004)
3-[(3-hydroxy-2-phenylpropanoyl)oxy]-8-methyl-8-azabicyclo[3.2.1]octan-6-yl (2e)-2-methylbut-2-enoate
C22H29NO5 (387.20456240000004)
5-[(1s,3e,4s,5s,6s,8s,9s,13r)-9-butyl-4-methyl-2,14-dioxa-10-azapentacyclo[6.5.1.0¹,⁵.0⁶,¹⁰.0⁹,¹³]tetradecan-3-ylidene]-4-methoxy-3-methylfuran-2-one
C22H29NO5 (387.20456240000004)
(4s,5r,6s)-4,5-dihydroxy-6-[5-(3-methylbut-2-en-1-yl)-1h-indole-3-carbonyloxy]-5,6-dihydro-4h-pyran-2-carboxylic acid
C20H21NO7 (387.13179560000003)
(1r,4z,7s)-4-ethylidene-7-methyl-6-methylidene-3,8,15-trioxo-2,9-dioxa-14-azatricyclo[9.5.1.0¹⁴,¹⁷]heptadeca-11(17),12-dien-7-yl acetate
C20H21NO7 (387.13179560000003)
(1r,3r,6r,13r,18r,19s,23r)-9-methoxy-10-methyl-4,17-dioxa-2,14,22-triazaheptacyclo[11.10.0.0²,⁶.0³,²¹.0⁷,¹².0¹⁴,¹⁸.0¹⁹,²³]tricosa-7,9,11-triene-8,11-diol
(1r,11r,13s,14s,15r)-14,15-dimethoxy-20-methyl-5,7,21-trioxa-20-azahexacyclo[11.4.3.1¹¹,¹⁴.0¹,¹³.0²,¹⁰.0⁴,⁸]henicosa-2,4(8),9-triene-16,19-dione
C20H21NO7 (387.13179560000003)
n-[(2s)-1-(4-methoxyphenyl)-3-oxo-4-(3,4,5-trimethoxyphenyl)butan-2-yl]carboximidic acid
(4z)-5-hydroxy-4-[(2e,4e,6r)-1-hydroxy-4-methyl-6-[(1r,3r,4s,5r)-1,4,8-trimethyl-2,9-dioxabicyclo[3.3.1]non-7-en-3-yl]hepta-2,4-dien-1-ylidene]-2h-pyrrol-3-one
C22H29NO5 (387.20456240000004)
(1s,3s,5r,8s,9r,10s,11r,14r,16s,17r,18s,19s)-9,10,19-trihydroxy-5-methyl-12-methylidene-7-azaheptacyclo[9.6.2.0¹,⁸.0⁵,¹⁷.0⁷,¹⁶.0⁹,¹⁴.0¹⁴,¹⁸]nonadecan-3-yl acetate
C22H29NO5 (387.20456240000004)
[10-hydroxy-7-(methylamino)-1-(3-methylbutyl)-6,9-dioxo-1h,3h,4h-naphtho[2,3-c]pyran-3-yl]acetic acid
3-{[(10s,13s)-11-hydroxy-10-isopropyl-9-methyl-3,9,12-triazatricyclo[6.6.1.0⁴,¹⁵]pentadeca-1,4,6,8(15),11-pentaen-13-yl]methoxy}-3-oxopropanoic acid
5-hydroxy-4-(1-hydroxy-4-methyl-6-{1,4,8-trimethyl-2,9-dioxabicyclo[3.3.1]non-7-en-3-yl}hepta-2,4-dien-1-ylidene)-2h-pyrrol-3-one
C22H29NO5 (387.20456240000004)
(3s,4r)-4-(5,7-dihydroxy-2-methyl-4-oxochromen-8-yl)-1-methylpiperidin-3-yl 2-methylbut-2-enoate
5-{13-butyl-5-methyl-7,14-dioxa-12-azatetracyclo[8.3.1.0³,¹².0⁴,⁸]tetradec-8-en-6-ylidene}-4-methoxy-3-methylfuran-2-one
C22H29NO5 (387.20456240000004)
1-[(4,5-dimethoxy-2-methylphenyl)methyl]-5,6,7-trimethoxy-1,2,3,4-tetrahydroisoquinoline
C22H29NO5 (387.20456240000004)
n-[(8s)-6-hydroxy-5,13,14,15-tetramethoxytricyclo[9.4.0.0²,⁷]pentadeca-1(15),2,4,6,11,13-hexaen-8-yl]ethanimidic acid
5-hydroxy-4-[(6r)-1-hydroxy-4-methyl-6-[(1r,3r,4s,5r)-1,4,8-trimethyl-2,9-dioxabicyclo[3.3.1]non-7-en-3-yl]hepta-2,4-dien-1-ylidene]-2h-pyrrol-3-one
C22H29NO5 (387.20456240000004)
(1s)-1-[(4,5-dimethoxy-2-methylphenyl)methyl]-5,6,7-trimethoxy-1,2,3,4-tetrahydroisoquinoline
C22H29NO5 (387.20456240000004)
3-({11-hydroxy-10-isopropyl-9-methyl-3,9,12-triazatricyclo[6.6.1.0⁴,¹⁵]pentadeca-1,4,6,8(15),11-pentaen-13-yl}methoxy)-3-oxopropanoic acid
(9r,10s)-16-hydroxy-4,5,14,15-tetramethoxy-10-methyl-10-azatetracyclo[7.7.1.0²,⁷.0¹³,¹⁷]heptadeca-1(16),2(7),3,5,13(17),14-hexaen-10-ium-10-olate
(2r,3r,4z)-5-[3-amino-2-(butoxycarbonyl)phenyl]-3-hydroxypent-4-en-2-yl furan-2-carboxylate
5-[3-amino-2-(butoxycarbonyl)phenyl]-3-hydroxypent-4-en-2-yl furan-2-carboxylate
6-hydroxy-4-(1h-imidazol-4-ylmethylidene)-9-(2-methylbut-3-en-2-yl)-2,5,16-triazatetracyclo[7.7.0.0²,⁷.0¹⁰,¹⁵]hexadeca-5,7,10,12,14-pentaen-3-one
(1s,3r,5r,6s,7r)-6-hydroxy-8-methyl-7-(1-methylpyrrole-2-carbonyloxy)-8-azabicyclo[3.2.1]octan-3-yl 1-methylpyrrole-2-carboxylate
(2e,4e,6e,8e,10z)-1-[(1s,4s,5r)-2,4-dihydroxy-4-(2-hydroxyethyl)-6-oxa-3-azabicyclo[3.1.0]hex-2-en-1-yl]-2,6,8,10-tetramethyldodeca-2,4,6,8,10-pentaen-1-one
C22H29NO5 (387.20456240000004)
(2r,3r)-3-{[(2s,3r)-2-{[(2e,4e)-1-hydroxy-4-methylhexa-2,4-dien-1-ylidene]amino}-3-phenylbutanoyl]oxy}-2-methylbutanoic acid
C22H29NO5 (387.20456240000004)
n-[1-(4-methoxyphenyl)-3-oxo-4-(3,4,5-trimethoxyphenyl)butan-2-yl]carboximidic acid
5-[(1s,3s,4r,5s,6e,10r,13r)-13-butyl-5-methyl-7,14-dioxa-12-azatetracyclo[8.3.1.0³,¹².0⁴,⁸]tetradec-8-en-6-ylidene]-4-methoxy-3-methylfuran-2-one
C22H29NO5 (387.20456240000004)
(1r,4r,6r,7s,17r)-4-(1-chloroethyl)-4,7-dihydroxy-6,7-dimethyl-2,9-dioxa-14-azatricyclo[9.5.1.0¹⁴,¹⁷]heptadec-11-ene-3,8-dione
16-ethyl-12-methyl-8-(4-methyl-5-oxooxolan-2-yl)-14-oxa-7-azatetracyclo[8.6.0.0¹,⁷.0¹¹,¹⁵]hexadec-10-ene-2,13-dione
C22H29NO5 (387.20456240000004)
n-{6-hydroxy-5,13,14,15-tetramethoxytricyclo[9.4.0.0²,⁷]pentadeca-1(15),2,4,6,11,13-hexaen-8-yl}ethanimidic acid
(9r)-16-hydroxy-4,5,14,15-tetramethoxy-10-methyl-10-azatetracyclo[7.7.1.0²,⁷.0¹³,¹⁷]heptadeca-1(16),2(7),3,5,13(17),14-hexaen-10-ium-10-olate
(1s,3r,5s,6s,8r,9s,10s,11r,14r,16s,17s,18r,19r)-3,6,19-trihydroxy-5-methyl-12-methylidene-7-azaheptacyclo[9.6.2.0¹,⁸.0⁵,¹⁷.0⁷,¹⁶.0⁹,¹⁴.0¹⁴,¹⁸]nonadecan-10-yl acetate
C22H29NO5 (387.20456240000004)